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DNA adducts formed by platinum-based anticancer
drugs interfere with DNA replication. The carrier ligand
of the platinum compound is likely to affect the confor-
mation of the Pt-DNA adducts. In addition, the confor-
mation of the adduct can also change upon binding of
damaged DNA to the active site of DNA polymerase.
From the crystal structures of pol b ternary complexes it
is evident that undamaged gapped and primed single-
stranded (non-gapped) DNA templates exist in very dif-
ferent conformations when bound to pol b. Therefore,
one might expect that the constraints imposed on the
damaged templates by binding to the polymerase active
site should also affect the conformation of the Pt-DNA
adducts and their ability to inhibit DNA replication. In
support of this hypothesis we have found that the effi-
ciency, carrier ligand specificity, site of discrimination
(3*-G versus 5*-G of the Pt-GG adducts), and fidelity of
translesion synthesis past Pt-DNA adducts by pol b are
strongly affected by the structure of the DNA template.
Previous studies have suggested that the conformation
of Pt-DNA adducts may be affected by the sequence con-
text of the adduct. In support of this hypothesis, our
data show that sequence context affects the efficiency,
fidelity, and pattern of misincorporation by pol b.
Platinum-based chemotherapeutic drugs exert their cyto-
toxic effect through binding to DNA. cis-diaminedichloroplati-
num(II)(cisplatin)1 (Fig. 1), which has been broadly used for
cancer treatment since 1978, and (trans-R,R)-1,2-diaminocyclo-
hexaneoxalatoplatinum(II) (oxaliplatin) (Fig. 1), which is cur-
rently in clinical trial in the United States and has been ap-
proved in several European countries for the treatment of
tumors with intrinsic and acquired resistance to cisplatin, both
form the same types adducts on the DNA (1, 2). Although the
most prevalent lesions created by interaction of both these
agents with DNA are bifunctional intrastrand 1,2-d(GpG)
cross-links, these adducts differ in the carrier ligands they
retain upon binding to DNA. Pt-DNA adducts formed by oxali-
platin contain (trans-R,R)-1,2-diaminocyclohexane (dach) car-
rier ligands, whereas the adducts formed by cisplatin contain
cis-diammine carrier ligands. Structures of the DNA contain-
ing cisplatin-GG adducts determined by NMR and x-ray crys-
tallography reveal significant distortion of base pairs in the
vicinity of the adduct (3–6). In addition, both the crystallo-
graphic and NMR structures show that the cisplatin adduct
causes a large positive roll in the helix resulting in compression
of the major groove and widening of the minor groove. Although
the conformation of oxaliplatin-GG adducts has not yet been
determined experimentally, a recent molecular modeling study
suggests that the overall conformation of cisplatin- and oxali-
platin-GG adducts are likely to be very similar. However, the
bulky dach ring of the oxaliplatin adduct fills much of the DNA
major groove, causing it to be narrower and less polar in the
area of the adduct. These subtle differences in overall DNA
conformation appear to influence the biological effects of the
Pt-DNA adducts. Thus, both the mismatch repair complex (7)
and high mobility group proteins (8) bind more strongly to
cisplatin-GG adducts than to oxaliplatin-GG adducts. In addi-
tion, eukaryotic DNA polymerases b, g, z, and h bypass oxali-
platin-GG adducts more readily than cisplatin-GG adducts
(8–10). Finally, the misincorporation frequency of DNA
polymerase b (pol b) is slightly greater with oxaliplatin-GG
adducts than with cisplatin-GG adducts on primed single-
stranded DNA (9). These data suggest that differences in the
conformation of oxaliplatin- and cisplatin-GG adducts can af-
fect both the efficiency and fidelity of translesion synthesis by
DNA polymerases, which could at least partially account for
differences in the cytotoxicity and mutagenicity of these Pt-
DNA adducts.
The conformation of Pt-DNA adducts in the active site of
DNA polymerases is likely to be different from that of adducted
DNA in solution. The fact that DNA templates are often bent
upon binding to the active site of DNA polymerases (11) sup-
ports this hypothesis. Unfortunately, whereas the conforma-
tion of mutagenic DNA adducts has been determined on a
variety of duplex DNAs in solution, relatively little is known
about how binding of the DNA templates to a polymerase active
site affects the conformation of the adduct and/or the nascent
base pair. The conformation of Pt-DNA adducts is clearly not
identical in all DNA polymerase active sites. Whereas pol b, g,
z, and h all bypass oxaliplatin adducts better than cisplatin
adducts, HIV-1 reverse transcriptase does not discriminate
between cisplatin and oxaliplatin adducts (8–10). In addition,
pol b, g, z, and h differ in the site of replication termination, the
site of discrimination between cisplatin- and oxaliplatin-GG
adducts (the 39-G or the 59-G) and the pattern of misincorpo-
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ration opposite the adduct (8–10). The conformation of the 6
nucleotide-gapped template bound to pol b has not been di-
rectly determined but is likely to be different from the confor-
mation of primed single-stranded DNA bound to pol b (12).
Studies on the efficiency, specificity (cisplatin versus oxalipla-
tin), and fidelity of translesion synthesis by pol b on primed
single-stranded and 6 nucleotide-gapped templates also sug-
gest that the manner in which the adduct binds to the active
site of the DNA polymerase could have significant biological
consequences. For example, pol b catalyzes 2.5-fold more trans-
lesion synthesis past oxaliplatin adducts than past cisplatin
adducts in experiments using single-stranded DNA, but does
not appear to differentiate between cisplatin and oxaliplatin
adducts during 6 nucleotide gap filling DNA synthesis (9). In
addition, the type of the DNA template used also influences the
effect of platinum adducts on the nucleotide insertion fidelity of
pol b (9).
In contrast to the situation with 6 nucleotide-gapped tem-
plates, the conformations of both primed single-stranded and
single nucleotide-gapped templates bound to the active site of
pol b are known and are quite different. For the primed single-
stranded template, the double-stranded region is bound to the
enzyme, whereas the single-stranded region does not interact
with the polymerase and thus, has considerable flexibility (13).
With a single nucleotide-gapped template both ends of the gap
are bound to enzyme, resulting in a 90° bend in the template
(12, 14). Steady-state and presteady-state kinetic analyses (15,
16) have shown that the catalytic efficiency and nucleotide
insertion fidelity of pol b are strongly influenced by the type of
DNA substrate (gapped versus non-gapped). Even though only
the structure of primed single-stranded template is likely to be
relevant to translesion synthesis by pol b in vivo, usage of
conformationally different DNA templates should serve as a
good model system to study influence of template structure on
translesion synthesis. Therefore, the present study was de-
signed to evaluate how the use of single nucleotide-gapped
DNA templates would affect the efficiency, carrier ligand spec-
ificity, and nucleotide insertion fidelity of DNA synthesis past
Pt-DNA adducts by pol b.
EXPERIMENTAL PROCEDURES
Construction of Platinum Adduct-containing Templates—Primer-
templates were constructed from synthetic oligonucleotides as de-
scribed previously (8). Briefly, platination reactions were carried out
with aquated derivatives of cisplatin (Sigma) and the active biotrans-
formation product of oxaliplatin, Pt(dach)Cl2 (provided by Dr. S. D.
Wyrick, UNC). Platination of a 12-mer oligonucleotide containing a
single GG sequence within a StuI restriction site (TCTAGGCCTTCT)
was performed for 2 h at 37 °C in the dark with a 2:1 drug/oligonucleo-
tide ratio. The oligonucleotides containing single platinum adducts
were separated from unplatinated oligonucleotides by 20% polyacryl-
amide gel electrophoresis.
The templates used for primer extension and steady-state kinetic
experiments are listed in Fig. 1. DNA templates (44-mer), with or
without platinum adduct, were constructed as described previously (8).
Briefly, platinated 12-mer or undamaged 12-mer (used for assembling
control DNA templates) were ligated with the 14-mer on the 59-end and
an 18-mer on the 39-end of the template using a 35-mer scaffold. After
16 h of ligation at 16 °C by T4 DNA ligase, templates were restricted by
StuI to ensure the absence of any unplatinated oligonucleotides and
purified on 12% denaturing polyacrylamide gels. Control experiments
were performed to ensure the purity of platinated templates as de-
scribed previously (8).
The 24- or 25-mer primers were 32P 59-end-labeled. The downstream
oligonucleotides (19- and 18-mer) used to form single nucleotide-gapped
templates were 59-end phosphorylated with unlabeled ATP. DNA sub-
strates were prepared by annealing undamaged or platinated 44-mer
templates with primers and downstream oligonucleotides at a 1.2:1:2
molar ratio. Annealing efficiencies were .99%, as evidenced by the
different mobility of the 32P-labeled primers before and after hybridiza-
tion to the template on non-denaturing polyacrylamide gels (data not
shown).
Steady-State Polymerization Kinetics—Recombinant human pol b
was generously provided by Dr. S. Wilson (NIEHS, National Institutes
of Health). The steady-state kinetic parameters Km and Vmax for dCTP
incorporation were measured as a function of deoxynucleotide concen-
tration (17, 18). Single nucleotide-gapped DNA templates (150 fmol)
were incubated at 37 °C in 10 ml-reaction mixtures containing 50 mM
Tris-HCl, pH 8.0, 10 mM MgCl2, 2 mM dithiothreitol, 20 mM NaCl, 200
mg/ml bovine serum albumin, 2.5% glycerol, 5 fmol of pol b, and variable
concentrations of dCTP. To determine the efficiency of nucleotide incor-
poration opposite the 39-G, dCTP concentrations ranged from 1 to 8 mM
for the undamaged template and from 16 to 256 mM for the platinated
templates. To determine efficiency of nucleotide incorporation opposite
the 59-G, dCTP concentrations ranged from 0.03 to 0.5 mM for the
undamaged template, from 16 to 256 mM for the cisplatin-containing
templates and from 0.25 to 4 mM for the oxaliplatin-containing template.
Reactions were terminated by mixing with 0.7 volumes of formamide-
loading dye containing 500 mM EDTA, 0.1% bromphenol blue in 90%
formamide and were then immediately transferred onto ice for 5 min.
Products were resolved by denaturing polyacrylamide gel electrophore-
sis (8 M urea, 16% acrylamide, 4 h at 2000 V) and then visualized and
quantified using a Molecular Dynamics PhosphorImager and Image-
Quant software. Initial time-course studies indicated that under stand-
ard conditions product formation was linear (i.e. conforms to steady-
state kinetics) for up to 4 min. Therefore, reactions were performed for
1 min for control DNA templates and for 2 min for platinated DNA
templates. Less than 20% of the primers were extended under these
conditions. The velocity of dCTP incorporation opposite the template
39-G and 59-G sites was determined as described previously (17, 18).
Vmax (the maximum reaction velocity) and Km (dCTP concentration at
which the reaction velocity is half-maximal) were determined from a
Hanes-Woolf plot by linear least squares fit (18). Values for the appar-
ent kcat were calculated based on the assumption that pol b was fully
active. The efficiency of nucleotide insertion by pol b was calculated as
kcat/Km. To facilitate comparison of values for different platinum ad-
ducts, the relative insertion efficiency frel was calculated as frel 5
(kcat/Km for Pt)/(kcat/Km for control). Because the steady-state kinetic
analysis utilized in these experiments produces an apparent rather
than a true Vmax (17, 18), Vmax and kcat values in the literature are
reported in a variety of units. The kcat values we report were obtained
by dividing Vmax (in nM primer extended per min) by the enzyme
concentration (0.5 nM). To compare these data with the Vmax and
Vmax/Km values reported in our previous kinetic analysis of translesion
synthesis by pol b with different DNA templates (9), these kcat and
kcat/Km values must be divided by 30. To compare these data with Vmax
values reported as nM min21, these kcat values must be multiplied by 5.
Primer Extension Assays Using Individual Nucleotides—To compare
the pattern of misincorporation opposite Pt-GG adducts on primed
single-stranded and gapped DNA templates, primer extension assays
were performed using each dNTP individually as described previously
(9). DNA templates (200 fmol expressed as primer termini) were incu-
bated with 5 fmol of pol b at 37 °C for 30 min in 10-ml reactions
containing 5 mM of each dNTP individually.
Kinetic Misincorporation Assays—To measure nucleotide misinser-
tion opposite Pt-GG adducts, 150 fmol of single nucleotide-gapped
DNA substrates were incubated with 5 fmol of pol b and variable
concentrations of dTTP or dATP. Reactions were performed for 5 min
for undamaged DNA templates and 10 min for platinated DNA tem-
plates. dTTP concentrations ranged from 5 to 100 mM for undamaged
and from 250 to 5000 mM for platinated templates. dATP concentra-
tions ranged from 25 to 400 mM for undamaged and from 200 to 3600
mM for platinated templates. The kinetics of nucleotide misincorpo-
ration opposite platinated and undamaged GG sites were determined
as described above. The misinsertion frequency (fmis) was determined
as the ratio of insertion efficiencies (kcat/Km) for incorrect and correct
nucleotides. The relative misinsertion frequency was determined as
fmis.rel 5 (fmis-Pt)/(fmis-control).
RESULTS AND DISCUSSION
In a previous study (9) we performed a kinetic analysis of
nucleotide incorporation opposite Pt-GG adducts in a 59-
AGGC-39 sequence by pol b using primed single-stranded DNA
templates and 6 or 5 nucleotide-gapped DNA templates. In
those studies, cisplatin-GG adducts inhibited nucleotide incor-
poration to a greater extent than oxaliplatin-GG adducts when
primed single-stranded templates were used, but pol b did not
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discriminate between cisplatin and oxaliplatin adducts during
short gap filling. In the present study we have examined the
catalytic efficiency and fidelity of pol b on DNA templates with
a single nucleotide gap opposite the 39- or 59-G of the 59-
AGGC-39 sequence in both undamaged templates and tem-
plates containing a single cisplatin- or oxaliplatin-GG adduct
(Fig. 1). These experiments are of interest because the confor-
mation of this type of DNA template bound to pol b is very
different from the templates with platinum adducts that have
been analyzed previously (14).
Effect of DNA Template Structure on Efficiency of dCTP
Incorporation—We performed steady-state kinetic assays for
dCTP insertion opposite the template 39- and 59-G on undam-
aged templates and templates with cisplatin and oxaliplatin
adducts by measuring nucleotide insertion at the first template
site adjacent to the primer terminus (18). All experiments were
carried out in the presence of a 30-fold excess of template over
enzyme. The results are summarized in Table I. One striking
observation was the 10-fold lower dCTP incorporation effi-
ciency (kcat/Km) opposite the 39-G relative to the 59-G on un-
damaged single nucleotide-gapped DNA. This appears to be
primarily an effect of sequence context on dCTP incorporation
efficiency (see below). However, the influence of sequence con-
text on the efficiency of dCTP incorporation opposite the gua-
nines also depends on template structure, because no signifi-
cant differences were observed in the kcat/Km for dCTP
incorporation opposite the 39- and 59-G in the same sequence
context with longer gapped or primed single-stranded DNA
templates (9).
The enzyme concentration, template concentration, and tem-
plate sequence used in these experiments are identical to those
used in our previous study of pol b (9). Thus, the kinetic
parameters obtained in this study can be directly compared
with the kinetic parameters reported in our previous study (9).
This allows a comparison of the efficiency and fidelity of trans-
lesion synthesis past platinum-DNA adducts by pol b with
single nucleotide-gapped templates (this study), 5 or 6 nucle-
otide-gapped templates (9), and primed single-stranded tem-
plates (9). Such a comparison indicates that the use of single
nucleotide-gapped DNA results in an increase in the efficiency
of nucleotide insertion (kcat/Km) by pol b on undamaged tem-
plates. Thus, dCTP incorporation opposite the 39- and 59-G was
2.5–30 and 10–120 times more efficient on single nucleotide-
gapped DNA than on the DNA with longer gaps and non-
gapped substrates, respectively. This is similar to the results
reported previously (15, 16).
Pt-GG adducts had different effects on the efficiency (kcat/
Km) of dCTP insertion opposite the 39-G and the 59-G (Table I).
There was a similar decrease in dCTP insertion efficiency
across from the 39-G of both platinum adducts (Table I). In
contrast, the efficiencies of dCTP incorporation opposite the
59-G were very different depending on carrier ligand of plati-
num adduct. There was a 170-fold decrease in insertion effi-
ciency for dCTP incorporation opposite the 59-G of cisplatin
adduct. This is the most significant inhibition of pol b catalytic
activity by a cisplatin adduct among all templates (gapped and
non-gapped) tested (compare Table I and results in Vaisman
and Chaney, Ref. 9). On the other hand, there was relatively
little inhibition of pol b catalytic efficiency opposite the 59-G of
the oxaliplatin adduct (Table I and Ref. 9). Thus, our data show
a very interesting variation in the carrier ligand specificity for
dCTP incorporation as the DNA template changes from primed
single-stranded to short-gapped (5 or 6 nucleotides) and to
single nucleotide-gapped. With the primed single-stranded
template, the efficiency of dCTP incorporation was about 2.5-
fold greater for the oxaliplatin adduct opposite the 39-G but was
about the same for the two adducts opposite the 59-G (9). With
the short-gapped DNA (5 and 6 nucleotides), no significant
differences were evident between templates with cisplatin and
oxaliplatin adducts in the insertion efficiency of dCTP opposite
either the 39-G or the 59-G (9). With the single nucleotide-
gapped template the efficiency of dCTP incorporation was
about 20-fold greater for the oxaliplatin adduct opposite the
59-G but was about the same for both adducts opposite the 39-G
(this study).
These differences could be related to the differences in the
conformation of the non-gapped and gapped DNA templates
bound to pol b. The x-ray crystal structure of pol b with a
non-gapped primed template shows that the double-stranded
region of the template is aligned in the palm subdomain of the
31-kDa domain of polymerase (13, 19). The thumb region (C-
terminal domain) closes around the DNA template to form a
binding pocket for the incoming dNTP (13, 19). Whereas the
double-stranded region and the template base for the incoming
dNTP are tightly constrained by the thumb and fingers in this
structure, the single-stranded region appears to have consid-
FIG. 1. Chemical structure of the platinum complexes (A), con-
figuration (B), and sequence (C) of single nucleotide-gapped
DNA templates used in primer-extension and kinetic studies.
The site-specifically modified DNA templates were constructed using a
combination of synthetic oligonucleotides as described under “Experi-
mental Procedures.” B shows a schematic representation of the DNA
template used to determine nucleotide incorporation opposite the 39-
and 59-G. The top panel of C shows the sequences of the template,
upstream primer, and downstream acceptor used to measure nucleotide
incorporation opposite the 39-G. It also shows the variations in the
sequence of the template and primer that were used to assess the effect
of changes in the base 39 to the target site on the efficiency of correct
nucleotide incorporation and the pattern of misinsertion. The bottom
panel of C shows the sequences of the template, upstream primer, and
downstream acceptor used to measure nucleotide incorporation oppo-
site the 59-G, along with the changes in sequence of the template and
acceptor used to assess the effect of the base 59 to the target base. The
GG sites of platinum adduct binding are underlined. In addition to the
templates shown here, primed single-stranded templates (in which down-
stream oligonucleotides were omitted) and templates with 5 or 6 nucleo-
tide gaps (in which downstream oligonucleotide was a 14-mer) were used
to compare pattern of misincorporation on structurally different DNA
templates. These templates have been described previously (9).
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erable flexibility (13, 19). In contrast, with single nucleotide-
gapped DNA the amino-terminal 8-kDa domain of pol b binds
to the downstream 59-phosphate. This anchors both ends of the
gap to the polymerase active site and results in a 90° bend in
the template DNA (12). Although a crystal structure of pol b
with a 6 nucleotide-gapped template is currently unavailable
because of the difficulty in obtaining an appropriate crystal
(12), it is likely that the conformation of the templates with
longer gaps are different from the conformation of single nu-
cleotide-gapped DNA. For example, with the one nucleotide-
gapped DNA, the 59-phosphate in the DNA gap is hydrogen
bonded to Lys-68 (14), whereas for the DNA with a gap greater
than one nucleotide, the 59-phosphate is hydrogen bonded to
Lys-35, Lys-68, Lys-72, and Lys-84 (20).
It is possible that the intrinsic conformation of the Pt-DNA
adducts in primed single-stranded and single nucleotide-
gapped DNA may also be different in solution. For example,
dramatic conformational differences were observed in NMR
solution structures of the (2)-trans-anti-[BP]dG adduct in sin-
gle nucleotide-gapped and primed single-stranded DNA tem-
plates (21, 22). However, because of the severe constraints
imposed on the gapped DNA when it binds to the active site of
pol b, we feel that the greatest conformational differences be-
tween Pt-DNA adducts on the templates we have used are
likely to be those imposed by the enzyme. These conformational
differences probably play a critical role in determining the
specificity, site and level of inhibition of nucleotide incorpora-
tion by the different Pt-DNA templates.
Nucleotide Misincorporation Opposite GGs on Undamaged
and Platinated Templates—The conformation of the adduct at
the active site of a DNA polymerase could also affect its muta-
genicity and the spectrum of mutations that are produced. To
obtain qualitative information about misincorporation across
from the platinum adducts, extension studies by pol b were
performed in the presence of 5 mM of either dCTP, dGTP, dTTP,
or dATP. Fig. 2 shows the results of these experiments when
both single-stranded and gapped templates were utilized. The
presence of a platinum adduct did not influence the apparent
pattern of nucleotide misincorporation. (Because the pattern of
misincorporation was identical for templates with cisplatin and
oxaliplatin adducts, only gels for templates with oxaliplatin
adducts are shown). However, as could be predicted based on
the different structures of pol b complexes with the non-gapped
and gapped DNA templates, both the location (39-G versus
59-G) and spectrum (dNTP inserted) of misincorporation by pol
b varied significantly depending on the structure of the DNA
template (Fig. 2). dTTP misincorporation was detected for most
DNA templates, except for incorporation opposite the 59-G on
single-stranded templates. None of the other nucleotides were
inserted opposite the 39-G or 59-G by pol b with primed single-
stranded DNA templates and templates with 5 or 6 nucleotide
gaps. However, the pattern of misincorporation opposite the
template 39-G and 59-G with single nucleotide-gapped DNA
templates was different. Pol b inserted dTTP much more
readily than dATP opposite the 39-G. Little or no misincorpo-
ration of dGTP opposite the 39-G could be detected, even fol-
lowing a prolonged reaction time and at increased enzyme
concentrations (data not shown). However, misincorporation of
all three nucleotides was observed across from the 59-G (Fig. 2).
To characterize the misincorporation efficiency on undam-
aged and platinated single nucleotide-gapped templates more
quantitatively and to compare these data to previously re-
ported kinetic parameters with non-gapped templates and tem-
plates with 5 or 6 nucleotide gaps (9), a steady-state kinetic
analysis of dTTP and dATP incorporation was performed (Ta-
ble II). Chagovetz et al. (16) have reported previously that the
nucleotide insertion fidelity of pol b was 10–100 times higher
on single nucleotide-gapped DNA compared with 6 nucleotide-
gapped DNA and primer-template with no gaps. In contrast to
this report, we observed an increased frequency (fmis) of dTTP
misincorporation opposite the undamaged 39- and 59-G resi-
dues for single nucleotide-gapped DNA compared with 5 or 6
nucleotide-gapped DNA and single-stranded DNA. The most
likely explanation for the differences between our results and
previous data (16) is the influence of the neighboring sequence
context. The influence of sequence context on the fidelity of
DNA polymerases has been reported previously (23, 24). For
example, Mendelman et al. (24) reported that the misincorpo-
ration frequency for DNA polymerase a and AMV RT varied by
10-fold for the same mispair in different locations of the DNA
template.
Cisplatin- and oxaliplatin-GG adducts had a similar effect on
the efficiency (kcat/Km) of dTTP misincorporation with single
nucleotide-gapped templates (Table II). Both adducts de-
creased the efficiency of dTTP incorporation by 30 to 40-fold
opposite the 39-G and 75 to 100-fold opposite the 59-G. However,
because cisplatin- and oxaliplatin-GG adducts had different
effects on the efficiency of correct (dCTP) nucleotide incorpora-
tion (9), they also had very different effects on the frequency of
misincorporation (fmis 5 (kcat/Km)dTTP/(kcat/Km)dCTP; Table II).
The frequency of dTTP misincorporation opposite the 39-G was
1.6-fold less for oxaliplatin adducts than for cisplatin adducts.
This was because of both a slight decrease in the efficiency of
dTTP incorporation (Table II) and a slight increase in the
efficiency of dCTP incorporation (Table I) for oxaliplatin ad-
ducts compared with cisplatin adducts. Opposite the 59-G the
TABLE I
Steady-state kinetic analysis of dCTP insertion opposite Pt-GG adducts
Kinetic assays were performed using 5 fmol of pol b and 150 fmol of the primer-templates shown in Fig. 1B. Incubation time was 1 min for
undamaged DNA substrates and 2 min for platinated DNA substrates. To determine the efficiency of nucleotide incorporation opposite the 39-G,
dCTP concentrations ranged from 1 to 8 mM for the undamaged template and from 16 to 256 mM for the platinated templates. To determine
efficiency of nucleotide incorporation opposite the 59-G, dCTP concentrations ranged from 0.03 to 0.5 mM for the undamaged template, from 16 to
256 mM for the cisplatin-containing templates and from 0.25 to 4 mM for the oxaliplatin-containing template. Kinetic parameters (Km and kcat) and
insertion efficiency (kcat/Km) for dCTP incorporation by pol b were determined using Hanes-Woolf plots. The relative insertion efficiency was
determined as frel 5 (kcat/Km/Pt)/(kcat/Km/control). Data for kcat, Km, and kcat/Km are means (6 S.E.) from five to six different experiments using two
independent template preparations.
Target
(template) Pt adduct kcat Km kcat/Km frel
min21 mM
39-G control 13.2 6 1.5 5.8 6 0.7 2.28 6 0.12
cisplatin 1.4 6 0.1 23.3 6 3.6 0.060 6 0.009 0.026
oxaliplatin 2.6 6 0.2 35.0 6 3.6 0.074 6 0.001 0.032
59-G control 4.5 6 0.01 0.20 6 0.04 23.4 6 2.3
cisplatin 3.0 6 0.02 27.7 6 6.6 0.11 6 0.02 0.005
oxaliplatin 4.8 6 0.03 1.5 6 0.3 3.2 6 0.3 0.14
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frequency of dTTP misincorporation was 16-fold less for oxali-
platin adducts than for cisplatin adducts, primarily because of
the relatively high efficiency of dCTP incorporation opposite
the 59-G of oxaliplatin adducts (Table I). This pattern of dTTP
misincorporation was significantly different from that observed
in the same sequence context with templates of different struc-
ture. The frequency of dTTP misincorporation opposite the 39-G
was 1.6 to 1.8-fold greater for oxaliplatin adducts than for
cisplatin adducts with single-stranded and 6 nucleotide-gapped
DNA templates (9). The pattern of dTTP misincorporation op-
posite the 59-G could not be quantitatively compared with those
templates because of the low frequency of dTTP misincorpora-
tion opposite the 59-G with single-stranded and 5 nucleotide-
gapped DNA templates.
In the qualitative experiments to determine the pattern of
misincorporation with single nucleotide-gapped DNA, a signif-
icant misinsertion of dATP was observed opposite the 59-G (Fig.
2). Therefore, we also determined kinetic parameters for dATP
incorporation at this site (Table II). The qualitative assessment
of misincorporation (Fig. 2) suggested that dTTP and dATP
were misincorporated with similar efficiencies opposite the
59-G on undamaged templates. However, quantitative meas-
urements (Table II) showed that pol b favored misincorporation
of dTTP by 6.5-fold compared with dATP on undamaged tem-
plates. This apparent discrepancy is explained by the fact that
difference in the efficiency of dATP and dTTP incorporation
was determined primarily by the differences in the Km values.
Because qualitative determination of the pattern of misincor-
poration was performed at saturating dNTP concentrations,
the Km-governed discrimination could not be detected in those
experiments. This finding indicates the importance of quanti-
tative analysis of primer extension on damaged and undam-
aged templates. In contrast to nucleotide incorporation on the
undamaged template, pol b catalyzed dTTP and dATP misin-
corporation with similar efficiency on platinated templates (Ta-
ble II). Thus, it is clear that both cisplatin- and oxaliplatin-GG
adducts increase the frequency of dATP misincorporation rel-
ative to dTTP misincorporation. Finally, in comparing the ox-
aliplatin- and cisplatin-GG adducts, the frequency of dATP
misincorporation opposite the 59-G was 17-fold greater for the
cisplatin adducts than for the oxaliplatin adducts.
The Effect of Sequence Context on the Efficiency and Fidelity
of pol b—As described above, the efficiency of dCTP incorpora-
tion was 10-fold greater opposite the 59-G than opposite the
39-G of the 59-AGGC-39 sequence on an undamaged single nu-
cleotide-gapped DNA template (Table I). In addition, the qual-
itative pattern of misincorporation on the single nucleotide-
gapped template was dTTP;dATP..dGTP for the 59-G and
dTTP..dATP for the 39-G (Fig. 2). With a primed single-
stranded DNA template, dTTP misincorporation was seen op-
posite the 39-G and no misincorporation could be observed
opposite the 59-G (Fig. 2). These data suggest that sequence
context, as well as template structure, strongly influences both
the efficiency and fidelity of pol b. To test this possibility, we
systematically altered the bases 59 and 39 to the GG sequence
with both single nucleotide-gapped and single-stranded tem-
plates. For the kinetic analysis of the dCTP incorporation, the
measurements were made with the single nucleotide-gapped
DNA template only (Fig. 1C), because no kinetic differences
had been observed previously for the 39- and 59-G in primed
single-stranded and longer gapped DNA templates (9). As can
be seen in Table III, alteration of the base 59 to the GG se-
quence had only a small effect on the efficiency of dCTP incor-
poration opposite the 59-G. In contrast, the efficiency of dCTP
FIG. 2. Specificity of nucleotide incorporation by pol b across from GG sites on undamaged DNA templates and templates with the
oxaliplatin adduct. Nucleotide incorporation studies were performed for 30 min using 200 fmol of DNA template, 5 fmol of pol b, and individual
dNTPs present at a 5 mM concentration. (C, incubation with dCTP; G, incubation with dGTP; T, incubation with dTTP; and A, incubation with
dATP.) Template sequence is indicated on the left (pr, primer).
TABLE II
Steady-state kinetic analysis of dTTP and dATP insertion opposite Pt-GG adducts
Kinetic assays were performed using 5 fmol of pol b and 150 fmol of the single nucleotide-gapped DNA templates shown in Fig. 1C. Bands
produced as a result of dATP misincorporation across from the 39-G were detectable but were too weak for reliable measurement of kinetic
parameters. Incubation time was 5 min for undamaged DNA templates and 10 min for platinated DNA templates. dTTP concentrations ranged
from 5 to 100 mM for undamaged and from 250 to 5000 mM for platinated templates. dATP concentrations ranged from 25 to 400 mM for undamaged
and from 200 to 3600 mM for platinated templates. Kinetic parameters (Km and kcat) and insertion efficiency (kcat/Km) for nucleotide insertion by
pol b were determined using Hanes-Woolf plots. The misinsertion efficiency (fmis) was determined as the ratio of incorrect (dTTP or dATP) to correct
(dCTP) insertion efficiencies (kcat/Km for dCTP incorporation are from Table 1). The relative misinsertion frequency was determined as fmis.rel 5
(fmis/Pt)/(fmis/control). Data are means (6 S.E.) from five to seven different experiments using two independent template preparations.
Template
base dNTP Pt adduct kcat Km kcat/Km fmis fmis.rel
min21 mM 3103 3104
39-G dTTP control 0.78 6 0.15 29 6 4 27.8 6 0.6 118
dTTP cisplatin 0.20 6 0.02 240 6 40 0.83 6 0.18 138 1.17
dTTP oxaliplatin 0.28 6 0.02 437 6 62 0.64 6 0.08 86 0.73
59-G dTTP control 0.111 6 0.006 4.6 6 0.3 24 6 2 10.6
dTTP cisplatin 0.15 6 0.02 634 6 26 0.24 6 0.02 21.8 2.06
dTTP oxaliplatin 0.19 6 0.02 600 6 55 0.32 6 0.02 1.0 0.094
dATP control 0.165 6 0.018 52 6 10 3.2 6 0.6 1.42
dATP cisplatin 0.150 6 0.019 702 6 88 0.21 6 0.02 19.1 13.4
dATP oxaliplatin 0.195 6 0.012 742 6 67 0.26 6 0.02 0.81 0.57
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incorporation was strongly influenced by the base 39 to the
adduct. The efficiency of dCTP incorporation opposite the 39-G
was low with a pyrimidine 39 to the GG sequence. However,
when a purine was 39 to the GG sequence, the efficiency of
dCTP incorporation opposite the 39-G was increased signifi-
cantly to a value that is similar to that seen opposite the 59-G
in the 59-AGGC-39 sequence. These data can best be explained
by a model in which a purine 39 to the templating G stabilizes
it in the active site of pol b through stacking interactions. These
data also suggest that the greater efficiency of dCTP incorpora-
tion opposite the 59-G in the original 59-AGGC-39 sequence was
primarily because of the presence of the adjacent 39-G.
To test how local DNA sequence context influences nucleo-
tide misinsertion, we carried out primer extension reactions
with individual nucleotides on templates with various nearest
neighbors adjacent to the target site (Fig. 3). On single nucle-
otide-gapped DNA, with a purine 39 to the target site, dTTP
misincorporation was about 2 times higher than dATP misin-
corporation (Fig. 3B). With a pyrimidine 39 to the target site,
pol b inserted dTTP 50–85-fold more efficiently than dATP
(Fig. 3A). In addition, the type of pyrimidine 39 to the target site
strongly influenced dNTP misincorporation. Levels of both
dTTP and dATP misincorporation were 10–60-fold higher with
C 39 to the target site than with T 39 to the target site. In
contrast, the template base 59 to the target site did not produce
a significant impact on the relative levels of dTTP and dATP
misincorporation. On primed single-stranded DNA templates,
dTTP misincorporation could be detected only when C was 39 to
the target site (Fig. 3, C and D). These data need to be inter-
preted with caution, because they have not been confirmed by
detailed kinetic analysis of misincorporation in different se-
quence contexts. However, the data do suggest that the previ-
ously observed differences in the pattern of misincorporation
opposite the 39- and 59-G in the 59-AGGC-39 sequence are
largely because of effects of the sequence context on the speci-
ficity of misincorporation. These data are also in agreement
with previous studies that showed that the base 39to the target
site has a significant effect on the misincorporation efficiency
by pol b (23, 24). We have not examined the effect of sequence
context on the efficiency and fidelity of translesion synthesis
past cisplatin- and oxaliplatin-GG adducts because of the need
to locate the platinum adduct in a restriction site for purposes
of purification of the platinated 44-mer and because of the
difficulty obtaining a unique platinum adduct in a GG sequence
with G either 39 or 59 to the adduct. However, the sequence
context of Pt-GG adducts is known to affect their mutagenicity
(25, 26) and Pilch et al. (27) have recently shown that sequence
context affects the conformation of Pt-GG adducts. Thus, it is
likely that sequence context will also affect both the efficiency
and fidelity of translesion synthesis past Pt-GG adducts by pol
b and other DNA polymerases.
Summary—In our previous reports (9) we have shown that
eukaryotic DNA polymerases pol b, g, z, and h all bypass
oxaliplatin-GG adducts to a greater extent than cisplatin-GG
adducts. However, the efficiency and accuracy of this bypass
was different for the each polymerase. This suggested that
translesion replication past Pt-DNA adducts was determined
by both the structure of the adduct and the DNA polymerase
involved in translesion synthesis. In the present study we show
that the replication blocking potential and mutagenicity of
Pt-DNA adduct is likely to be strongly influenced by con-
straints imposed on the template when it binds to the active
site of the polymerase. In support of this hypothesis we have
shown that for translesion synthesis past Pt-DNA adducts by
pol b the specificity (cisplatin versus oxaliplatin), the site of
discrimination (39-G versus 59-G), and the pattern of misincor-
poration is strongly dependent on the DNA template structure.
These differences are most likely because of changes in the
conformation of Pt-DNA adducts when structurally different
DNA templates are bound to the active site of pol b. Thus,
whereas the conformation of DNA adducts is most often stud-
ied in solution in the absence of any protein, these data suggest
that conformational studies of DNA adducts in the active site of
the polymerases responsible for translesion synthesis will be
important for an understanding of mutagenesis mechanisms.
Our data also show that sequence context affects the efficiency
of correct nucleotide incorporation and the pattern of misincor-
poration by pol b. Whereas these data were obtained with
TABLE III
Influence of sequence context on the efficiency of dCTP insertion
Kinetic assays were performed for 1 min using 5 fmol of pol b and 150
fmol of the single nucleotide-gapped DNA templates shown in Fig. 1C.
To determine the efficiency of nucleotide incorporation opposite the
39-G, dCTP concentrations ranged from 1 to 8 mM for the template with
C and T 39 to the target site and from 0.03 to 0.5 mM for the template
with G and A 39 to the target site. To determine the efficiency of
nucleotide incorporation opposite the 59G, dCTP concentrations ranged
from 0.03 to 0.5 mM. The insertion efficiency (kcat/Km) for dCTP incor-
poration by pol b were determined using Hanes-Woolf plots (see “Ex-




Base 39 to the
target site




39-G C G 2.28 6 0.12
G G 12.0 6 2.1
T G 1.0 6 0.2
A G 13.7 6 2.4
59-G G A 23.4 6 2.3
G G 18.9 6 2.5
G T 27.0 6 2.8
G C 32.5 6 3.1
FIG. 3. Nearest neighbor influence on the specificity of nucle-
otide incorporation by pol b opposite the 3*-G (A and C) and the
5*-G (B and D) on single nucleotide-gapped (A and B) and single-
stranded (C and D) DNA templates. Nucleotide incorporation stud-
ies were performed for 30 min using 200 fmol of DNA template, 5 fmol
of pol b, and individual dNTPs present at a 5 mM concentration. (C,
incubation with dCTP; G, incubation with dGTP; T, incubation with
dTTP; and A, incubation with dATP.) Template sequence is indicated on
the left, template structure and position of the target site (underlined)
is shown on the top. l represents the 32P-labeled primer.
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undamaged DNA, sequence context is also likely to affect the
efficiency and fidelity of translesion synthesis past Pt-DNA
adducts as well. Elucidation of structural features of Pt-DNA
adducts in the active site of pol b will be required to define the
mechanism of these effects.
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